Latest News
Search News
KEYNOTE-522: Immune therapy for breast cancer
30th September 2019
Results of an interim analysis from the KEYNOTE-522 trial have shown a treatment combination of immunotherapy plus chemotherapy to improve response rates in patients with early triple-negative breast cancer. Prof Peter Schmid presented the results at the ESMO Congress 2019 in Barcelona, Spain.
Read more
Urine test for pancreatic cancer starts clinical study
25th September 2019
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients. If successful, this non-invasive urine test would be the first in the world to help clinicians detect the highly lethal cancer at an early stage – enabling many more people to have surgery to remove their tumour, which is currently the only potentially curative treatment.
Read more
Blood test for prostate cancer
17th September 2019
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, in a study led by BCI’s Professor Yong-Jie Lu.
Read more
BRCA testing for higher risk group
13th September 2019
Researchers are calling for population-wide BRCA testing in the Jewish community after finding it to be more effective than current approaches, cost effective and to have a high satisfaction rate with those undergoing testing.
Read more
Blood Cancer Awareness Month 2019
1st September 2019
Today marks the start of Blood Cancer Awareness Month. Our researchers are committed to work to understand the biology of blood cancer and harness this knowledge to identify new treatment strategies to help those affected.
Read more
Introducing Dr Barrie Peck
14th August 2019
Introducing new Group Leader, Dr Barrie Peck We are pleased to welcome Dr Barrie Peck to the CRUK Barts Centre as a new Group Leader. We recently spoke with Barrie […]
Read more